Tong Yu Selected Research

gadofullerene

1/2020	Light-assisted gadofullerene nanoparticles disrupt tumor vasculatures for potent melanoma treatment.
1/2020	Amino acid modified gadofullerene protects against insulin resistance induced by oxidative stress in 3T3-L1 adipocytes.
1/2019	Gadofullerene Nanoparticles Reverse Dysfunctions of Pancreas and Improve Hepatic Insulin Resistance for Type 2 Diabetes Mellitus Treatment.
1/2019	Photo-triggered gadofullerene: enhanced cancer therapy by combining tumor vascular disruption and stimulation of anti-tumor immune responses.
1/2018	RF-assisted gadofullerene nanoparticles induces rapid tumor vascular disruption by down-expression of tumor vascular endothelial cadherin.
1/2017	Amino acid functionalized gadofullerene nanoparticles with superior antitumor activity via destruction of tumor vasculature in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tong Yu Research Topics

Disease

26	Neoplasms (Cancer) 07/2022 - 09/2010
9	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2010
7	COVID-19 06/2022 - 03/2021
7	Infections 02/2022 - 05/2013
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 09/2014
5	Wounds and Injuries (Trauma) 06/2022 - 11/2018
5	Fibrosis (Cirrhosis) 10/2021 - 10/2018
5	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2017
4	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2016
4	Inflammation (Inflammations) 06/2022 - 01/2018
4	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 11/2018
4	Osteonecrosis (Kienbock's Disease) 01/2022 - 06/2013
3	Carcinogenesis 03/2022 - 01/2017
3	Hemorrhage 01/2022 - 08/2018
3	Intervertebral Disc Displacement (Herniated Disc) 01/2022 - 02/2021
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2021 - 10/2018
3	Hypoxia (Hypoxemia) 01/2021 - 11/2017
3	Necrosis 12/2020 - 01/2018
3	Scoliosis 04/2019 - 08/2018
2	Acute Lung Injury 05/2022 - 01/2021
2	Flushing 03/2022 - 02/2017
2	Pain (Aches) 01/2022 - 03/2021
2	Edema (Dropsy) 12/2021 - 01/2021
2	Fever (Fevers) 06/2021 - 03/2021
2	Delirium 01/2021 - 10/2020
2	Radiculopathy (Radiculopathy, Cervical) 01/2021 - 03/2020
2	Insulin Resistance 01/2020 - 01/2019
2	Chronic Disease (Chronic Diseases) 06/2019 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 01/2017
2	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2014
1	Brain Death (Brain Dead) 08/2022
1	Hematologic Neoplasms (Hematological Malignancy) 03/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Atrial Fibrillation 01/2022

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 03/2022 - 07/2012
7	Long Noncoding RNAIBA 10/2021 - 10/2018
6	CytokinesIBA 04/2021 - 01/2020
6	gadofullereneIBA 01/2020 - 01/2017
5	Pharmaceutical PreparationsIBA 07/2022 - 02/2017
5	Biological ProductsIBA 04/2021 - 06/2017
5	MicroRNAs (MicroRNA)IBA 01/2021 - 09/2014
4	AntigensIBA 02/2022 - 07/2012
4	Therapeutic UsesIBA 01/2022 - 01/2017
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 11/2018
3	Epithelial Sodium ChannelsIBA 05/2022 - 01/2021
3	VaccinesIBA 01/2022 - 03/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2017
3	RNA (Ribonucleic Acid)IBA 06/2021 - 01/2021
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 10/2015
3	MicellesIBA 07/2020 - 01/2020
3	Amino Acids FDA Link 01/2020 - 01/2017
3	LipidsIBA 01/2020 - 01/2017
2	Immune Checkpoint InhibitorsIBA 07/2022 - 01/2022
2	SolutionsIBA 01/2022 - 02/2017
2	Harmine (Telepathine)IBA 01/2022 - 06/2019
2	artemisinin-naphthoquine combinationIBA 01/2022 - 01/2021
2	AntioxidantsIBA 12/2021 - 01/2020
2	Bleomycin (Blenoxane)FDA LinkGeneric 10/2021 - 10/2018
2	Viral RNAIBA 06/2021 - 03/2021
2	AntibodiesIBA 06/2021 - 03/2021
2	Interleukin-6 (Interleukin 6)IBA 04/2021 - 12/2020
2	Messenger RNA (mRNA)IBA 01/2021 - 09/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 10/2018
2	ChitosanIBA 07/2020 - 02/2020
2	Insulin (Novolin)FDA Link 01/2020 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2020 - 01/2019
2	Alanine (L-Alanine)FDA Link 01/2020 - 01/2017
2	cadherin 5IBA 01/2020 - 01/2018
2	erucylphosphocholineIBA 05/2019 - 05/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 09/2010
2	IodineIBA 01/2018 - 04/2017
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2017 - 01/2017
2	Carrier Proteins (Binding Protein)IBA 01/2017 - 01/2017
2	Caspase 3 (Caspase-3)IBA 01/2017 - 05/2013
2	EpitopesIBA 03/2015 - 05/2013
2	Peptides (Polypeptides)IBA 03/2015 - 07/2012
2	heparanaseIBA 03/2015 - 07/2012
1	Cytidine Triphosphate (CTP)IBA 08/2022
1	deoxyribonuclease II (DNASE II)IBA 06/2022
1	APTIBA 06/2022
1	Proteolysis Targeting ChimeraIBA 03/2022
1	Sulfides (Thioethers)IBA 03/2022
1	HMPL-013IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Discoidin Domain Receptor 2IBA 01/2022

Therapy/Procedure

14	Therapeutics 03/2022 - 07/2012
6	Diskectomy (Discectomy) 01/2022 - 03/2020
5	Drug Therapy (Chemotherapy) 01/2022 - 04/2017
3	Stents 01/2022 - 01/2020
3	Pedicle Screws 04/2019 - 08/2018
2	Operative Time 01/2022 - 08/2018
2	Length of Stay 01/2022 - 03/2021
2	Punctures 10/2020 - 06/2020
2	Immunotherapy 07/2020 - 01/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2019 - 12/2016
1	Thrombectomy 01/2022
1	Chemoprevention 01/2022